News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Paula Miller

Advertisement

Paula Miller is an attorney at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.

Articles by Paula Miller

Combination Products: Regulatory and Patent Issues You Should Consider Now

ByShana K. Cyr,Paula Miller,Deborah M. Herzfeld,Robert F. Shaffer
February 23rd 2017

The authors discuss regulatory and patent issues with combination products.

Advertisement

Latest Updated Articles

  • Combination Products: Regulatory and Patent Issues You Should Consider Now
    Combination Products: Regulatory and Patent Issues You Should Consider Now

    Published: February 23rd 2017 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Industry Outlook 2026: Trends Transitioning from 2025 into 2026

2

Amgen Acquires UK Biotech Dark Blue Therapeutics

3

Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP

4

Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining

5

Navigating Financial and Opportunity Risks in Accelerated Drug Launches

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us